Vitamin E suppementation in phenytoin induced developmental toxicity in rats: Postnatal study

Neuroendocrinology Letters

Volumn 27, Issue SUPPL. 2, 2006, Pages 69-73

  Mach, Mojmír ^a   Dubovický, Michal ^a   Navarová, Jana ^a   Kovačovský, Pavel ^b   Ujházy, Eduard ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

Developmental toxicity; Intrauterine hypoxia; Phenytoin; Rat; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; PHENYTOIN; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY GROWTH; BRAIN WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG MEGADOSE; FEMALE; GROWTH REGULATION; LONG TERM CARE; LOW BIRTH WEIGHT; MALE; NONHUMAN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; POSTNATAL GROWTH; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PUERPERIUM; RAT; SURVIVAL RATE; VITAMIN SUPPLEMENTATION; WEIGHT GAIN; WEIGHT REDUCTION; WISTAR RAT; ANIMAL; ARTICLE; BREEDING; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; DRUG EFFECT; EVALUATION; FETAL WELL BEING; FETUS HYPOXIA; GROWTH, DEVELOPMENT AND AGING; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; REFLEX;

ANIMALS; ANIMALS, NEWBORN; DIETARY SUPPLEMENTS; FEMALE; FETAL HYPOXIA; FETAL VIABILITY; GROWTH AND DEVELOPMENT; MALE; PHENYTOIN; PREGNANCY; PREGNANCY, ANIMAL; PRENATAL EXPOSURE DELAYED EFFECTS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REFLEX; VITAMIN E;

EID: 34047232954     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Adams J. Methods in behavioral teratology. In: Riley EP, Vorhees CV, editors. Handbook of Behavioral Teratology, NY: Plenum; 1986. p. 67-97.
2. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, Dzietko M, Pesditschek S, Mai I, Dikranian K, Olney JW, Ikonomidou C. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA. 2002; 99:15089-94
3. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr. 2002; 76:703-16.
4. Cedeberg J, Siman CM, Eriksson UJ. Combined treatment with vitamin E and vitamin C decrease oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res. 2001; 49:755-62.
5. Cohen-Kerem R, Koren G. Antioxidants and fetal protection against ethanol teratogenicity. I. Review of the experimental data and implications to humans. Neurotoxicol Teratol. 2003; 25:1-9.
6. Danielsson MK, Danielsson BR, Marchner H, Lundin M, Rundqvist E, Reiland S. Histopathological and hemodynamic studies supporting hypoxia and vascular disruption as explanation to phenytoin teratogenicity. Teratology. 1992; 5:485-97.
7. Dubovický M, Ujházy E, Kovačovský P, Navarová J. Effect of melatonin on neurobehavioral development of rats. Biologia. 2005; 60(Suppl 17):37-40.
8. Elmazar MM, Sullivan FM. Effect of prenatal phenytoin administration on postnatal development of the rat: a behavioral teratology study. Teratology. 1981; 2:115-24.
9. Hanson JW, Smith DW. The fetal hydantoin syndrome. J Pediatr. 1975;2:285-90.
10. Harbison RD, Becker BA. Diphenylhydantoin teratogenicity in rats. Toxicol Appl Pharmacol. 1974; 22:193-200.
11. Little RE, Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol. 1999; 13(5):347-52.
12. Mach M, Ujházy E, Dubovický M, Kovačovský P, Navarová J. High-dose vitamin E supplementation in phenytoin-induced intra-uterine hypoxia: teratological study. Biologia. 2005; 60(Suppl 17):45-9.
13. Martin MM, Hurley LS. Effect of large amounts of vitamin E during pregnancy and lactation. Am J Clin Nutr. 1977; 30:1629-37.
14. McCartney MA, Scinto PL, Wang SS, Altan S. Developmental effects of phenytoin may differ depending on sex of offspring. Neurotoxicol Teratol. 1999; 2:119-28.
15. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005; 142:37-46.
16. Neff LM. High-dose vitamin E supplementation and mortality. Nutr Clin Care. 2005; 8:3-5.
17. Ohmori HT, Kobayashi T, Yasuda M. Neurotoxicity of phenytoin administered to newborn mice on developing cerebellum. Neurotoxicol Teratol. 1992; 14:159-65.
18. Ornoy A, Zaken V, Kohen R. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies. Teratology. 1999; 60:376-386.
19. Penn JS, Talmon BL, Bullard LE. Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity. Free Radical Bio Med. 1997; 22:977-84.
20. Skufca P, Brandsch C, Hirche F, Eder K. Effects of a dietary thermally oxidized fat on thyroid morphology and mRNA concentrations of thyroidal iodide transporter and thyroid peroxidase in rats. Ann Nutr Metab. 2003; 47:207-13.
21. Sullivan FM, McElhatton PR. Teratogenic activity of the antiepileptic drugs phenobarbital, phenytoin, and primidone in mice. Toxicol Appl Pharmacol. 1975; 34(2):271-82.
22. Štípek S, Měchurová A. Reactive oxygen species involved in the mechanism of perinatal derangements [in Czech]. Čs Gynekol. 1995; 2:199-212.
23. Ujházy E, Dubovický M, Mach M, Juránek I, Navarová J, Sadloňová I, Gajdošík A. Effect of phenytoin on prenatal and postnatal development of rats. Biologia. 2000; 55:125-30.
24. Vorhees CV. Methods in behavioral teratology screening: current status and new developments. Congenital Anom. 1987; 27:111-24.
25. Zaken V, Kohen R, Ornoy A. Vitamins C and E improve rat embryonic antioxidant defense mechanism in diabetic culture medium. Teratology. 2001; 64:33-44.